In a somber end to an FDA advisory committee’s two-day scouring of multiple drugmakers’ oncology data, Pfizer’s pitch to ...

Former Sanofi subsidiary Zentiva has signed off on up to 220 million euros for the rights to commercialize and manufacture an ...

Helping compensate for the funding shortfall is the Novo Nordisk Foundation, which has pledged up to 380 million Danish ...

Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...

Decades into its tenure as a drug seller, CSL Behring has finally dipped its toe into the waters of TV advertising. | Decades ...

Healthcare professionals (HCPs) may need a reminder that their LGBTIQ+ patients are more than just their cancer diagnoses. | ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Johnson & Johnson has won the support of an FDA expert panel in its bid to make Darzalex the first treatment for an early ...

…Busy Philipps, that is. Supernus tapped the actor and actual Qelbree user to head up a new direct-to-consumer campaign ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...